A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC), a highly malignant digestive system tumor, poses substantial challenges due to its intricate underlying causes and pronounced post-surgery recurrence. Consequently, the prognosis for HCC remains notably unfavorable. The endorsement of sorafenib and PD-L1 inhibitors fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Julu, Liang, Rong, Lu, Cheng, Lu, Lu, Li, Shuanghang, Tang, Minchao, Huang, Xi, Huang, Shilin, Mai, Rongyun, Gao, Xing, Li, Shizhuo, Zeng, Can, Lin, Yan, Ye, Jiazhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487462/
https://www.ncbi.nlm.nih.gov/pubmed/37686291
http://dx.doi.org/10.3390/ijms241713486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487462/
https://www.ncbi.nlm.nih.gov/pubmed/37686291
http://dx.doi.org/10.3390/ijms241713486

Ejemplares similares